Eterna Therapeutics Inc. (ERNA)
NASDAQ: ERNA · IEX Real-Time Price · USD
2.150
-0.040 (-1.83%)
At close: Jul 19, 2024, 4:00 PM
2.160
+0.010 (0.47%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Eterna Therapeutics Market Cap
Eterna Therapeutics has a market cap or net worth of $11.63 million as of July 22, 2024. Its market cap has decreased by -4.65% in one year.
Market Cap
11.63M
Enterprise Value
49.87M
1-Year Change
-4.65%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since December 1, 1998, Eterna Therapeutics's market cap has decreased from $21.10M to $11.63M, a decrease of -44.87%. That is a compound annual growth rate of -2.29%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 11.60M | 19.59% |
Dec 29, 2023 | 9.70M | 2.11% |
Dec 30, 2022 | 9.50M | -95.62% |
Dec 31, 2021 | 217.00M | 3,187.88% |
Dec 31, 2020 | 6.60M | 3.13% |
Dec 31, 2019 | 6.40M | 14.29% |
Dec 31, 2018 | 5.60M | -47.17% |
Dec 29, 2017 | 10.60M | -44.79% |
Dec 30, 2016 | 19.20M | 29.73% |
Dec 31, 2015 | 14.80M | -63.55% |
Dec 31, 2014 | 40.60M | -10.18% |
Dec 31, 2013 | 45.20M | 203.36% |
Dec 31, 2012 | 14.90M | -1.97% |
Dec 30, 2011 | 15.20M | -34.20% |
Dec 31, 2010 | 23.10M | -15.07% |
Dec 31, 2009 | 27.20M | 262.67% |
Dec 31, 2008 | 7.50M | -78.07% |
Dec 31, 2007 | 34.20M | -54.22% |
Dec 29, 2006 | 74.70M | -6.74% |
Dec 30, 2005 | 80.10M | -52.55% |
Dec 31, 2004 | 168.80M | -3.87% |
Dec 31, 2003 | 175.60M | 272.03% |
Dec 31, 2002 | 47.20M | 42.17% |
Dec 31, 2001 | 33.20M | 52.29% |
Dec 29, 2000 | 21.80M | -79.57% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Ontrak | 11.90M |
Check-Cap | 11.88M |
Monopar Therapeutics | 11.86M |
Lumos Pharma | 11.85M |
Imunon | 11.75M |
RedHill Biopharma | 11.58M |
Cardio Diagnostics Holdings | 11.57M |
Calidi Biotherapeutics | 11.30M |